A graphical sensitivity analysis for clinical trials with non-ignorable missing binary outcome

Statistics in Medicine

Volumn 21, Issue 24, 2002, Pages 3823-3834

  Hollis, Sally ^a  

^a LANCASTER UNIVERSITY   (United Kingdom)

Author keywords

Binary data; Intention to treat; Missing data; Randomized control trial; Sensitivity analysis

Indexed keywords

ARTICLE; BINOMIAL DISTRIBUTION; CLINICAL TRIAL; DATA ANALYSIS; HUMAN; RANDOMIZATION; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL PARAMETERS;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BINOMIAL DISTRIBUTION; CORONARY ARTERY BYPASS; CORONARY RESTENOSIS; DATA DISPLAY; DATA INTERPRETATION, STATISTICAL; HUMANS; RANDOMIZED CONTROLLED TRIALS; STENTS; TREATMENT OUTCOME;

EID: 0037203162     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/sim.1276     Document Type: Article

References (30)

1. Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutic trials. Journal of Chronic Diseases 1967; 20:637-648.
2. Lewis JA, Machin D. Intention to treat - who should use ITT?. British Journal of Cancer 1993; 68:647-650.
3. ICH E9 Expert Working Group Statistical principles for clinical trials. ICH Harmonised Tripartite Guideline. Statistics in Medicine 1999; 18:1905-1942.
4. Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomized controlled trials. British Medical Journal 1999; 319:670-674.
5. The Post Coronary Artery Bypass Graft Trial Investigators. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. New England Journal of Medicine 1997; 336:153-162.
6. Baker SG, Laird NM. Regression analysis for categorical variables with outcome subject to non-ignorable non-response. Journal of the American Statistical Association 1988; 83:62-69.
7. Savage MP, Douglas JS Jr, Fischman DL, Pepine CJ, King SB 3rd, Werner JA, Bailey SR, Overlie PA, Fenton SH, Brinker JA, Leon MB, Goldberg S. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo Trial Investigators. New England Journal of Medicine 1997; 337:740-747.
8. Rubin DB. Inference and missing data. Biometrika 1976; 81:701-708.
9. Little RA, Rubin DB. Statistical Analysis with Missing Data. Wiley: New York, 1987.
10. Michiels B, Molenberghs G, Lipsitz SR. Selection models and pattern-mixture models for incomplete data with covariates. Biometrics 1999; 55:978-983.
11. Senn S. Testing for baseline balance in clinical trials. Statistics in Medicine 1994; 13:1715-1726.
12. Fuchs C. Maximum likelihood estimation and model selection in contingency tables with missing data. Journal of the American Statistical Association 1982; 77:270-278.
13. Molenberghs G, Goetghebeur EJT. Simple fitting algorithms for incomplete categorical data. Journal of the Royal Statistical Society, Series B 1997; 59:401-414.
14. Baker SG. Composite linear models for incomplete multi-nomial data. Statistics in Medicine 1994; 13: 609-622.
15. Molenberghs G, Goetghebeur EJT, Lipsitz SR, Kenward MG. Nonrandom missingness in categorical data: strengths and limitations. The American Statistician 1999; 53:110-118.
16. Molenberghs G, Michiels B, Kenward MG, Diggle PJ. Monotone missing data and pattern-mixture models Statistica Neerlandica 1998; 52:153-161.
17. Little RJA. Pattern-mixture models for multivariate incomplete data. Journal of the American Statistical Association 1993; 88:125-134.
18. Silagy C, Stead LF. Physician advice for smoking cessation Cochrane Review In The Cochrane Library. Update Software: Oxford, 2001; Issue 4.
19. The EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. New England Journal of Medicine 1997; 336:1689-1696.
20. Sackett DL, Richardson WS, Rosenberg WS, Haynes RB. Evidence-based Medicine. Churchill Livingstone: New York, 1997.
21. Unnebrink K, Windeler J. Sensitivity analysis by worst and best case assessment: is it really sensitive?. Drug Information Journal 1999; 33:835-839.
22. Delucchi KL. Methods for the analysis of binary outcome results in the presence of missing data. Journal of Consulting and Clinical Psychology 1994; 62:569-575.
23. Shadish WR, Hu X, Glaser RR, Kownacki R, Wong S. A method for exploring the effects of attrition in randomized experiments with dichotomous outcomes. Psychological Methods 1998; 3:3-22.
24. Choi SC, Lu IL. Effect of non-random missing data mechanisms in clinical trials. Statistics in Medicine 1995; 14:2675-2684.
25. Hogan JW, Laird NM. Intention-to-treat analyses for incomplete repeated measures data. Biometrics 1996; 52:1002-1017.
26. Little R, Yau L. Intent-to-treat analysis for longitudinal studies with drop-outs. Biometrics 1996; 52:1324-1333.
27. Forster JJ, Smith PWF. Model-based inference for categorical survey data subject to non-ignorable non-response. Journal of the Royal Statistical Society, Series B, 1998; 60:57-70.
28. Goetghebeur EJT, Shapiro SH. Analysing non-compliance in clinical trials: ethical imperative or mission impossible? Statistics in Medicine, 1996; 15:2813-2826.
29. Frangakis CE, Rubin DB. Addressing complications of intention-to-treat analysis in the combined presence of all-or-none treatment-non-compliance and subsequent missing outcomes, Biometrika 1999; 86:365-379.
30. Nordheim EV. Inference for non-randomly missing categorical data: an example from a genetic study on Turners syndrome. Journal of the American Statistical Association 1984; 79:772-780.